Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3006598	ua-ph	— (—)	423	433	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Postpartum care and examination

+∞

15.58

1.2

0.0

—

Diabetes mellitus in pregnancy

6.41

14.18

1.1

—

Antenatal screening

+∞

12.31

1.2

0.0

—

Complications of labour and delivery

6.01

12.11

1.1

1.0

—

Supervision of high-risk pregnancy

+∞

11.85

1.1

0.0

—

Gestational diabetes (for exclusion)

4.76

11.09

1.2

1.1

—

Maternal care for known or suspected abnormality of pelvic organs

6.20

10.16

1.3

1.1

—

Supervision of normal pregnancy

+∞

9.92

1.1

0.0

—

Pregnancy examination and test

+∞

9.44

1.2

0.0

—

Outcome of delivery

+∞

9.42

1.1

0.0

—

Other obstetric conditions, not elsewhere classified

4.09

8.75

1.1

—

Maternal care for other known or suspected fetal problems

5.28

8.52

1.1

—

Labour and delivery complicated by fetal stress [distress]

5.41

8.41

1.3

1.0

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

3.93

8.04

1.2

1.1

—

Other maternal disorders predominantly related to pregnancy

4.25

7.11

1.1

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

3.84

6.36

1.2

1.1

—

Other acute lower respiratory infections

268

2.06

6.27

1.1

1.0

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

4.40

6.20

1.1

—

Perineal laceration during delivery

5.82

6.02

1.2

1.0

—

Postpartum haemorrhage

5.74

5.64

1.3

1.0

—

Persons encountering health services in circumstances related to reproduction

232

1.92

5.50

1.0

—

Maternal care for known or suspected malpresentation of fetus

5.73

5.47

1.2

1.1

—

Obstructed labour due to malposition and malpresentation of fetus

6.39

5.42

1.2

1.0

—

Pregnancy hypertension

3.46

5.00

1.1

1.2

—

Procreative management

213

1.96

4.68

1.0

—

Acute bronchiolitis

247

1.88

4.24

1.0

—

Postpartum hemorraghe, all women as controls

3.14

3.94

1.3

1.1

—

Long labour

4.71

3.73

1.4

1.0

—

Ischemic heart diseases

230

0.37

3.71

1.0

—

Conjunctivitis (acute, non atopic)

288

1.77

3.66

1.0

—

Certain conditions originating in the perinatal period

230

1.82

3.64

1.0

—

Hard cardiovascular diseases

252

0.40

3.63

1.0

—

Major coronary heart disease event

227

0.37

3.58

1.0

—

Emergency coronary revascularization (for ACS)

227

0.37

3.53

1.0

—

Acute suppurative otitis media

225

1.83

3.50

1.0

—

Coronary revascularization (ANGIO or CABG)

227

0.38

3.48

1.0

—

Percutaneous Coronary Intervention

227

0.38

3.47

1.0

—

Acute pharyngitis

127

2.11

3.27

1.0

—

Atopic dermatitis, strict definition

309

1.68

3.24

1.1

1.0

—

ILD medications

270

0.48

3.21

1.1

1.0

—

Gestational [pregnancy-induced] hypertension

3.52

3.18

1.0

1.1

—

Lack of expected normal physiological development

162

1.92

3.15

1.0

—

Continuous positive airway pressure

224

1.73

3.06

1.0

—

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

7.51

3.05

1.2

1.3

—

Preterm labour and delivery

7.50

3.05

1.3

1.0

—

Diseases of middle ear and mastoid

242

1.69

3.05

1.0

—

Other problems related to primary support group, including family circumstances

298

1.67

3.04

1.0

—

Dermatitis due to ingested food

202

1.82

3.01

1.0

—

Bronchitis

161

1.76

3.01

1.1

1.0

—

Prolonged pregnancy

3.98

3.01

1.0

1.1

—

Cough

242

1.72

2.94

1.0

—

Otitis media, unspecified

189

1.81

2.89

1.0

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

331

1.61

2.86

1.0

—

310

1.63

2.84

1.0

—

Pre-eclampsia or poor fetal growth

2.76

2.79

1.1

1.2

—

Suppurative and unspecified otitis media

237

1.68

2.77

1.0

—

Other heart diseases, wide

278

0.51

2.74

1.0

—

Heart failure, not strict

130

0.31

2.74

1.0

—

Malignant neoplasm, wide definition for exclusion

209

0.45

2.68

1.0

—

Disorders of tooth development and eruption

218

1.67

2.68

1.0

—

Pre-eclampsia

4.21

2.67

1.1

1.2

—

Pre-eclampsia or eclampsia

4.21

2.67

1.1

1.2

—

Viral infections characterized by skin and mucous membrane lesions

332

1.54

2.63

1.0

—

Liveborn infants according to place of birth

2.29

2.56

1.0

—

Diarrhoea and gastroenteritis of presumed infectious origin

332

1.55

2.54

1.0

—

Persons encountering health services in other circumstances

171

1.80

2.49

1.1

1.0

—

Antihypertensive medication - note that there are other indications

198

0.48

2.48

1.0

1.1

—

All influenza

2.11

2.48

1.2

1.0

—

Other puerperal infections

3.82

2.46

1.5

1.1

—

Fever of other and unknown origin

200

1.69

2.42

1.0

—

Malignant neoplasm

202

0.47

2.42

1.0

—

First line medication for Crohn's disease

269

0.56

2.37

1.2

1.0

—

Infections of genitourinary tract in pregnancy

6.26

2.37

1.0

1.1

—

Respiratory and cardiovascular disorders specific to the perinatal period

281

1.59

2.35

1.0

—

Covid-19 suspected case

132

1.90

2.35

1.0

—

Asthma-related infections

323

1.55

2.33

1.0

—

Asthma, hospital admission 2, infections

323

1.55

2.33

1.0

—

Inflammatory bowel disease treatment related agents

218

0.51

2.32

1.1

1.0

—

Exclusions for E4_PCOS_CONSORTIUM

166

0.41

2.30

1.0

1.1

—

Any event in cancer register

228

0.52

2.29

1.1

1.0

—

Benign neoplasms

212

0.52

2.23

1.0

—

Neoplasms

325

0.62

2.22

1.0

—

Use of hypnotics and sedatives

174

0.46

2.22

1.0

—

Soft tissue disorders

301

0.62

2.17

1.0

—

ILD medications: prednisolone, methylprednisolone, prednisone

212

0.53

2.15

1.1

1.0

—

Intestinal infectious diseases

341

1.45

2.11

1.0

—

Malaise and fatigue

133

0.36

2.03

1.0

—

Other general symptoms and signs

153

1.76

2.02

1.0

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

140

1.79

2.00

1.1

1.0

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified

140

1.79

2.00

1.1

1.0

—

Codes for special purposes

263

1.56

1.98

1.0

—

Provisional assignment of new diseases of uncertain etiology

263

1.56

1.98

1.0

—

Postpartum hemorraghe, parous women as controls

2.17

1.96

1.3

1.1

—

Maternal care for other conditions predominantly related to pregnancy

3.02

1.96

1.3

1.2

—

Atopic dermatitis, strict definition with reimbursement

263

1.54

1.94

1.1

1.0

—

Other viral diseases, not elsewhere classified

312

1.50

1.92

1.0

—

Delayed milestone in childhood

284

1.52

1.91

1.0

—

Acute laryngitis and tracheitis

134

1.76

1.85

1.0

—

Conjunctivitis

332

1.43

1.84

1.1

1.0

—

Other heart diseases

232

0.56

1.80

1.0

—

Other disorders of ear

224

0.56

1.79

1.0

—

Other complications of labour and delivery, not elsewhere classified

3.06

1.79

1.1

1.0

—

Influenza and pneumonia

329

1.37

1.73

1.0

—

Solid cancers, helper endpoint

138

0.47

1.72

1.0

—

Medical treatment for female infertility

2.49

1.72

1.0

1.2

—

Fall on same level

344

0.68

1.68

1.0

—

Diseases of oesophagus, stomach and duodenum

193

0.56

1.68

1.2

1.0

—

Other bacterial diseases

276

0.62

1.68

1.0

—

Inguinal hernia

128

0.47

1.66

1.0

—

Respiratory distress of newborn

273

1.50

1.66

1.0

—

Cardiovascular diseases (excluding rheumatic etc)

354

0.68

1.66

1.0

—

All influenza (not pneumonia)

2.10

1.65

1.1

1.0

—

Acute appendicitis

2.16

1.61

1.2

1.1

—

Intracranial injury

256

1.48

1.57

1.0

—

Hypertension

156

0.54

1.55

1.1

1.0

—

Hypertensive diseases

156

0.54

1.55

1.1

1.0

—

Arthropathies

198

0.61

1.54

1.0

1.1

—

Inflammatory disorders of breast

3.34

1.52

1.4

1.2

—

Disorders of conjunctiva

332

1.38

1.52

1.1

1.0

—

Injuries to the knee and lower leg

173

0.58

1.50

1.1

—

Parasetamol

2.00

1.48

1.1

—

Other viral diseases

331

1.41

1.47

1.0

—

Condition for Implicit Sepsis (Organ dysfunction codes)

226

0.59

1.46

1.0

—

Haemorrhage in early pregnancy

2.78

1.46

1.0

1.2

—

Other functional intestinal disorders

302

1.41

1.45

1.0

—

Peritonsillar abscess

2.73

1.43

1.2

—

Appendicitis, broad definition

2.05

1.43

1.2

1.1

—

Diseases of appendix

2.04

1.42

1.2

1.1

—

Used for control exclusion in common control thyroid runs

325

0.71

1.42

1.0

—

False labour

2.34

1.41

1.2

1.1

—

Other soft tissue disorders, not elsewhere classified

286

0.68

1.41

1.1

1.0

—

Autoimmune diseases

297

0.70

1.41

1.0

—

Complications predominantly related to the puerperium

2.25

1.40

1.6

1.1

—

Female infertility

2.02

1.39

1.2

—

Acute appendicitis, no complications

2.24

1.39

1.2

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

275

1.44

1.39

1.0

—

Hypertensive diseases (excluding secondary)

154

0.57

1.37

1.1

1.0

—

Non-allergic asthma (mode), excluding more controls

1.84

1.36

1.0

—

Non-allergic asthma (mode)

1.84

1.36

1.0

—

Diarrhoea and gastroenteritis of presumed infectious origin

307

1.33

1.32

1.0

—

Disorders of psychological development

293

1.40

1.31

1.0

—

Dental pulpitis, including avohilmo

1.74

1.30

1.2

1.1

—

Cardiovascular diseases

364

0.74

1.30

1.0

—

Carpal tunnel syndrome

2.52

1.29

1.2

1.1

—

Asthma and allergy, excluding more controls

1.84

1.29

1.1

1.0

—

Recurrent or chronic depression

2.34

1.28

1.1

—

144

1.44

1.27

1.1

1.0

—

Atopic dermatitis

274

1.38

1.26

1.1

1.0

—

Other joint disorders

169

0.62

1.25

1.0

1.1

—

Non-invasive ventilation

104

0.43

1.25

1.0

—

Acute upper respiratory infections of multiple and unspecified sites

167

1.46

1.25

1.1

1.0

—

Convulsions, not elsewhere classified

184

1.50

1.24

1.0

—

Anxiety (asthma-related co-morbidities)

1.84

1.23

1.0

1.2

—

Metabolic disorders

178

0.62

1.21

1.0

—

Menorrhagia

0.00

1.21

0.0

1.1

—

Nonsuppurative otitis media

212

1.43

1.20

1.0

—

Valvular heart disease excluding rheumatic fever

146

0.54

1.20

1.0

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

304

1.37

1.19

1.0

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

0.00

1.19

0.0

1.0

—

Heart failure and coronary heart disease

0.00

1.19

0.0

1.0

—

Asthma-related pneumonia

140

1.57

1.18

1.1

1.0

—

Asthma-related pneumonia or sepsis

140

1.57

1.18

1.1

1.0

—

Asthma, hospital admissions 3, pneumonia

140

1.57

1.18

1.1

1.0

—

Appendectomy

1.95

1.18

1.2

1.1

—

Mental retardation, excluding more controls

168

1.51

1.18

1.0

—

Spontaneous abortion

1.86

1.17

1.1

—

Other disorders starting during childhood or adolecense, excluding more controls

213

1.44

1.17

1.0

—

Abnormal involuntary movements

0.00

1.16

0.0

1.0

—

Female infertility, associated with anovulation

2.50

1.15

1.2

1.1

—

Carcinoma in situ of cervix uteri

2.50

1.15

1.2

—

In situ neoplasms

2.50

1.15

1.2

—

Crowding of teeth, including avohilmo

0.44

1.14

1.0

—

Molar incisor enamel hypoplasia

192

1.46

1.13

1.0

—

Bleeding

211

0.64

1.12

1.0

—

Pneumonias (Asthma/COPD co-morbidities)

328

1.29

1.12

1.0

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

313

1.34

1.12

1.0

—

Benzodiazepine use

135

0.56

1.09

1.0

1.1

—

Viral and other specified intestinal infections

234

1.40

1.09

1.0

—

Functional dyspepsia

2.38

1.09

1.6

1.1

—

Episodal and paroxysmal disorders

340

0.76

1.08

1.0

—

All chronic kidney diseases

200

0.61

1.08

1.0

—

Autoimmune diseases excluding thyroid diseases

258

0.72

1.08

1.0

—

Childhood allergy (age < 16)

299

1.32

1.07

1.0

—

Asthma and allergy

1.76

1.06

1.2

1.0

—

All pneumoniae

330

1.28

1.05

1.0

—

All anxiety disorders

1.73

1.05

1.0

1.2

—

Speech and linguistic disorders, excluding more controls

215

1.40

1.03

1.0

—

Autoimmune diseases excluding thyroid diseases, strict definition

256

0.73

1.02

1.0

—

Pain in throat and chest

108

0.56

1.02

1.0

—

Leiomyoma of uterus

0.00

1.02

0.0

1.1

—

Oral corticosteroids

0.54

1.01

1.0

1.1

—

Maternal care for known or suspected fetal abnormality and damage

2.26

1.01

1.0

1.1

—

Disorders of breast

1.90

1.01

1.2

—

Insomnia

1.55

1.00

1.1

—

Sleep disorders (combined)

208

0.71

1.00

1.0

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

339

1.32

1.00

1.0

—

Viral and other specified intestinal infections

184

1.43

0.99

1.0

—

Other disorders of penis

131

1.53

0.99

1.0

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

328

1.27

0.99

1.0

—

Type 2 diabetes, definitions combined, including avohilmo

1.87

0.99

1.3

1.1

—

Excluding asthma or asthma-COPD overlap

105

1.43

0.98

1.1

1.0

—

Other pulmonary diagnosis

105

1.43

0.98

1.1

1.0

—

COPD differential diagnosis

105

1.43

0.98

1.1

1.0

—

ILD differential diagnosis

105

1.43

0.98

1.1

1.0

—

Pneumonia, organism unspecified

307

1.28

0.97

1.0

—

Cramp and spasm

0.00

0.97

0.0

1.0

—

Hernia

183

0.66

0.96

1.1

1.0

—

Other specific joint derangements/joint disorders

153

0.63

0.95

1.0

1.1

—

Care involving use of rehabilitation procedures

285

1.32

0.95

1.0

—

Other diseases of biliary tract

0.00

0.95

0.0

1.0

—

Other bacterial diseases

238

0.71

0.94

1.0

—

Persons with potential health hazards related to communicable diseases

353

1.29

0.92

1.0

—

135

1.39

0.92

1.1

1.0

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

135

1.39

0.92

1.1

1.0

—

ILD medications: immunosuppressive drugs

237

0.67

0.89

1.1

1.0

—

Other diseases of urinary system

204

0.72

0.89

1.1

1.0

—

Chronic apical periodontitis

0.56

0.87

1.1

—

Polycystic ovarian syndrome, consortium definition

0.51

0.86

1.2

1.1

—

Pain in limb

271

0.74

0.86

1.0

—

Biguanides

1.81

0.84

1.4

1.1

—

Female infertility, cervical, vaginal, other or unspecified origin

1.81

0.84

1.1

1.2

—

Implicit Sepsis

199

0.68

0.84

1.0

—

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

264

1.33

0.83

1.0

—

Open wound of wrist and hand

1.65

0.82

1.0

1.1

—

Other diseases of upper respiratory tract

327

0.80

0.82

1.0

—

Asthma, hospital admissions , main diagnosis only

351

1.26

0.82

1.0

—

Finngen Rheumatological endpoints

0.60

0.81

1.3

1.1

—

297

1.30

0.81

1.0

—

Heart failure and antihypertensive medication

0.00

0.80

0.0

1.0

—

Other nutritional deficiencies

138

1.43

0.80

1.0

1.1

—

Fitting and adjustment of other devices

0.00

0.79

0.0

1.0

—

Inflammatory diseases of female pelvic organs

0.50

0.79

1.4

1.1

—

Event of undetermined intent

0.00

0.79

0.0

1.0

—

Suicide or other Intentional self-harm

0.00

0.79

0.0

1.2

—

Abrasion of teeth

0.00

0.79

0.0

1.1

—

Asthma, unspecified (mode)

1.57

0.78

1.1

1.0

—

Allergic asthma (mode)

1.56

0.78

1.1

1.0

—

Allergic asthma (mode), excluding more controls

1.56

0.78

1.1

1.0

—

L04AA Selective immunosuppressants

0.52

0.78

1.0

—

Caries of dentine, including avohilmo

261

0.78

0.77

1.0

—

Diseases of male genital organs

178

0.74

0.76

1.0

—

Bitten or struck by other mammals

1.77

0.76

1.0

1.1

—

Asthma, unspecified (mode), excluding more controls

1.56

0.76

1.1

1.0

—

Acne

0.00

0.76

0.0

1.1

—

Type 2 diabetes

1.70

0.76

1.3

1.1

—

Noninfective enteritis and colitis

252

1.31

0.75

1.1

1.0

—

Poor fetal growth

2.08

0.74

1.0

1.2

—

Hyperkinetic disorders, excluding more controls

127

1.43

0.73

1.0

—

Postpartum haemorrhage due to retained placenta

1.84

0.73

1.3

1.1

—

Other noninfective gastroenteritis and colitis

236

1.31

0.73

1.1

1.0

—

Congenital malformations of great arteries

271

0.72

0.73

1.0

—

Congenital malformations, deformations and chromosomal abnormalities

266

1.28

0.73

1.0

—

Other disorders of bone

2.00

0.72

1.0

1.1

—

Obesity, other/unspecified

1.80

0.72

1.1

—

Valvular operations

107

0.56

0.72

1.0

—

Glomerular diseases

107

0.56

0.72

1.0

—

Disorders of the thyroid gland

143

0.68

0.71

1.2

1.0

—

Persons encountering health services for specific procedures and health care

335

0.80

0.71

1.0

—

Haemangioma, any site

1.58

0.71

1.0

—

Haemangioma and lymphangioma, any site

1.58

0.71

1.0

—

All kidney diseases

305

0.78

0.70

1.1

1.0

—

Gastro-oesophageal reflux disease

147

0.65

0.70

1.0

—

Medical abortion

0.51

0.69

1.4

1.1

—

Childhood asthma (age<16)

1.43

0.69

1.0

—

Childhood asthma (age<16), excluding more controls

1.43

0.69

1.0

—

Depression medications

1.68

0.67

1.0

—

Dental caries

188

1.33

0.67

1.0

—

Concussion

253

1.26

0.67

1.0

—

Transport accidents

0.53

0.67

1.0

1.1

—

Pain in joint

123

0.67

1.0

—

Hypoglycaemia, other or unspecified

1.63

0.66

1.0

—

Other metabolic disorders

1.63

0.66

1.0

—

Hypoplasia of dental enamel , including avohilmo

157

1.37

0.66

1.0

—

Excessive earwax

152

0.64

0.66

1.0

—

Congenital malformations, deformations and chromosomal abnormalities

271

1.26

0.66

1.0

—

Other anxiety disorders

1.59

0.66

1.0

1.2

—

Depression or dysthymia

1.67

0.66

1.1

—

Specific personality disorders

1.79

0.66

1.0

1.1

—

Congenital malformations of the circulatory system

303

1.25

0.65

1.0

—

Other (not insulin) diabetes medications

1.69

0.64

1.4

1.1

—

Pneumonia derived septicemia

1.73

0.64

1.0

—

Type 2 diabetes, strict (exclude DM1)

1.68

0.64

1.4

1.1

—

Type 2 diabetes, definitions combined

1.68

0.64

1.4

1.1

—

Polycystic ovarian syndrome, broad definition

1.72

0.64

1.2

1.1

—

HSIL lesion of the cervix uteri

1.72

0.64

1.2

—

Injuries to the neck

1.72

0.64

1.0

1.1

—

Effects of foreign body entering through natural orifice

129

0.62

0.63

1.0

—

Diseases of the respiratory system

102

1.33

0.63

1.1

1.0

—

Sensorineural hearing loss

0.57

0.63

1.0

—

Arthrosis

0.00

0.63

0.0

1.2

—

Renal failure

0.59

0.62

1.0

—

Pulmonary artery stenosis

0.00

0.62

0.0

1.0

—

Necrosis of pulp, including avohilmo

1.63

0.61

1.1

1.2

—

Acute lymphadenitis

1.67

0.61

1.0

—

HSIL lesion of the cervix uteri, vagina or vulva

1.67

0.61

1.2

—

Noninfectious colitis NAS

113

1.42

0.61

1.1

1.0

—

Malignant neoplasm of adrenal gland

0.00

0.61

0.0

1.0

—

Cholecystectomy

1.66

0.60

1.4

1.2

—

Malignant neoplasm of adrenal gland, including Hilmo

0.00

0.60

0.0

1.0

—

Nutritional anaemias

142

1.36

0.60

1.1

1.0

—

Family history of certain disabilities and chronic diseases leading to disablement

0.00

0.60

0.0

1.1

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

0.00

0.60

0.0

1.2

—

Congenital malformations of cardiac septa

298

1.24

0.59

1.0

—

Acne vulgaris

0.00

0.59

0.0

1.2

—

LSIL lesion of the cervix uteri

0.00

0.59

0.0

1.2

—

LSIL lesion of the cervix uteri, vagina or vulva

0.00

0.59

0.0

1.2

—

Phobic anxiety disorders

0.00

0.59

0.0

1.2

—

Disorders of other endocrine glands

321

1.23

0.58

1.0

—

Cystitis

159

0.75

0.58

1.2

1.0

—

Infectious mononucleosis

0.00

0.58

0.0

1.1

—

Other neurological diseases

0.60

0.58

1.0

—

Amblyopia ex anopsia

114

0.61

0.58

1.0

—

COPD/asthma/ILD related infections

135

1.26

0.57

1.1

1.0

—

COPD/asthma related infections

135

1.26

0.57

1.1

1.0

—

Abdominal and pelvic pain

306

0.84

0.57

1.1

1.0

—

Obesity

1.46

0.57

1.1

—

Obesity and other hyperalimentation

1.46

0.57

1.1

—

Disorders of adult personality and behaviour

1.67

0.56

1.0

1.2

—

Chronic kidney disease

0.58

0.56

1.0

—

Cardiac arrhythmias

0.63

0.56

1.1

1.0

—

293

1.23

0.56

1.0

—

Sleep apnoea

0.62

0.55

1.0

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

136

0.72

0.55

1.2

1.1

—

Mental retardation, wide definition

202

1.28

0.55

1.0

—

Mental retardation

202

1.28

0.55

1.0

—

Acute upper respiratory infections

168

1.25

0.55

1.0

—

Dyspnoea

161

0.73

0.54

1.1

1.0

—

Hypothyroidism, other/unspecified

136

0.73

0.54

1.2

1.1

—

GASTRO-related operations

298

0.84

0.54

1.0

—

Any gastric operation

298

0.84

0.54

1.0

—

Sleep apnoea, including avohilmo

0.66

0.53

1.0

—

Other diseases of hard tissues of teeth

228

0.82

0.53

1.0

—

Chronic diseases of tonsils and adenoids

305

0.83

0.53

1.0

—

Mixed specific developmental disorders

214

1.26

0.53

1.0

—

Other strabismus

240

1.25

0.52

1.0

—

Symptoms and signs involving the digestive system and abdomen

323

0.85

0.51

1.1

1.0

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

1.29

0.50

1.1

1.0

—

Specific development disorders of speech and language

242

1.24

0.50

1.0

—

Diseases of the musculoskeletal system and connective tissue

317

0.85

0.50

1.0

—

Polyarthropathies

0.64

0.50

1.0

1.1

—

Neurotic, stress-related and somatoform disorders

1.38

0.49

1.0

1.1

—

Otalgia

107

0.65

0.48

1.0

—

Anxiety disorders

1.37

0.48

1.0

1.1

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

109

0.64

0.48

1.0

—

Migraine

1.35

0.48

1.2

1.1

—

Urticaria

208

1.25

0.47

1.0

—

Anisometropia and aniseikonia

1.49

0.47

1.0

—

L04AD Calcineurin inhibitors

143

0.70

0.47

1.0

—

Osteopathies and chondropathies

1.48

0.47

1.0

1.1

—

Abnormalities of breathing

283

0.84

0.47

1.1

1.0

—

Iron deficiency anaemia

135

1.31

0.47

1.1

1.0

—

Other disorders of glucose regulation and pancreatic internal secretion

1.46

0.46

1.0

—

Non-rheumatic valve diseases

0.68

0.46

1.0

—

Transitory disorders of carbohydrate metabolism specific to fetus and newborn

277

1.22

0.46

1.0

—

Other respiratory conditions originating in the perinatal period

1.55

0.46

1.0

—

Other special examinations and investigations of persons without complaint or reported diagnosis

147

0.79

0.46

1.0

—

Other and unspecified dermatitis

142

0.70

0.46

1.0

—

Transitory endocrine and metabolic disorders specific to fetus and newborn

277

1.21

0.46

1.0

—

Other and unspecified iron deficiency

120

1.33

0.45

1.1

1.0

—

Strabismus

245

1.22

0.45

1.0

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

104

0.71

0.45

1.3

1.1

—

Emotional disorders starting during childhood or adolecense, excluding more controls

1.39

0.44

1.1

1.0

—

Intestinal infectious diseases

298

1.15

0.44

1.0

—

Asthma (diagnoses ohter than nonallergic)

334

1.17

0.44

1.1

1.0

—

Caries of enamel

297

1.17

0.44

1.0

—

Anxiety disorders, excluding more controls

1.39

0.44

1.0

1.1

—

Personality disorders

1.61

0.43

1.0

1.1

—

Personality disorders, excluding more controls

1.61

0.43

1.0

1.1

—

Speech and linguistic disorders

273

1.20

0.43

1.0

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

142

0.77

0.43

1.1

—

Polyp of the female genital tract

0.00

0.42

0.0

1.3

—

Renal tubulo-interstitial diseases

253

0.82

0.42

1.1

1.0

—

Iron deficiency

1.43

0.42

1.0

—

Infections specific to the perinatal period

0.63

0.42

1.0

—

Certain infectious and parasitic diseases

281

1.14

0.42

1.0

—

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

262

1.20

0.42

1.0

—

Dislocation, sprain and strain of joints and ligaments of head

1.56

0.42

1.0

—

Other specified/unspecified hearing loss

1.56

0.42

1.0

—

Other abnormal uterine and vaginal bleeding

0.00

0.42

0.0

1.1

—

Acute bronchitis

208

1.23

0.41

1.1

1.0

—

Fetus and newborn affected by maternal conditions that may be unrelated to present pregnancy

1.42

0.41

1.0

—

Other abnormal immunological findings in serum

0.00

0.41

0.0

1.0

—

Effects of other external causes

0.00

0.41

0.0

1.0

—

Personal history of malignant neoplasm

0.00

0.41

0.0

1.0

—

Other noninflammatory disorders of vulva and perineum

0.00

0.41

0.0

1.1

—

Fracture at wrist and hand level

1.51

0.41

1.0

1.1

—

Other abnormal products of conception

1.36

0.41

1.1

1.2

—

Social phobias

0.00

0.41

0.0

1.3

—

Other systemic involvement of connective tissue

0.00

0.41

0.0

1.2

—

Rheumatoid arthritis, including avohilmo

0.00

0.41

0.0

1.2

—

Urticaria and erythema

240

1.21

0.41

1.0

—

Congenital aortic valve stenosis

0.00

0.41

0.0

1.0

—

Torsion of testis

0.00

0.40

0.0

1.0

—

Haemorrhagic and haematological disorders of fetus and newborn

274

1.19

0.40

1.0

—

Disorders of gallbladder, biliary tract and pancreas

0.73

0.40

1.2

1.1

—

Hypoplasia of dental enamel, prenatal , including avohilmo

106

1.35

0.40

1.0

—

Second line medication for Crohn's disease

172

0.76

0.40

1.1

1.0

—

Hypoplasia of dental enamel

105

1.34

0.40

1.0

—

Congenital absence, atresia and stenosis of large intestine

1.47

0.40

1.0

—

Meniscus derangement

0.00

0.40

0.0

1.2

—

Hernia of abdominal wall

1.33

0.40

1.0

—

Right ventricular outflow tract obstruction

104

0.67

0.40

1.0

—

Other diseases of pleura

121

0.72

0.40

1.0

—

Gastroduodenal ulcer

0.00

0.40

0.0

1.0

—

Other diseases of lip and oral mucosa

1.36

0.40

1.0

—

Collagenous colitis

1.43

0.39

1.4

1.0

—

Superficial injury of forearm

1.43

0.39

1.0

1.1

—

Abnormal findings on examination of blood, without diagnosis

0.66

0.39

1.0

—

Congenital malformations of heart and great arteries

306

1.17

0.39

1.0

—

Papilloedema, unspecified

1.39

0.38

1.0

—

Conductive and sensorineural hearing loss

0.69

0.38

1.0

—

Migraine without aura

1.34

0.38

1.2

1.0

—

Obesity due to excess calories

1.32

0.37

1.0

1.1

—

Mycoses

167

0.78

0.37

1.0

1.1

—

Other hearing loss

1.36

0.37

1.0

—

Birth asphyxia

1.30

0.37

1.0

—

Congenital malformations of great veins

0.62

0.37

1.0

—

Scabies

1.30

0.37

1.1

1.0

—

Reimbursement for rheumatic diseases

115

0.69

0.37

1.4

1.0

—

STROKE

0.63

0.36

1.0

—

Disorders of choroid and retina

0.63

0.36

1.0

1.1

—

Other arrhythmias

0.65

0.36

1.2

1.1

—

Other congenital malformations of male genital organs

0.65

0.36

1.0

—

Other and unspecified mental retardation

188

1.22

0.36

1.0

—

Cholelithiasis, broad definition with cholecystitis

1.44

0.36

1.3

1.1

—

Septal defects

312

1.16

0.36

1.0

—

Other symptoms and signs involving the digestive system and abdomen

0.65

0.35

1.0

—

Allergic rhinitis

285

0.83

0.35

1.1

1.0

—

L04AX Other immunosuppressants

168

0.77

0.35

1.1

1.0

—

Atrial septal defect, secundum type

211

0.80

0.35

1.0

—

Other disorders starting during childhood or adolescence

270

1.18

0.35

1.0

—

Left ventricular outflow tract obstruction, narrow definition

123

0.73

0.35

1.0

—

Conotruncal defects

145

0.75

0.35

1.0

—

Complications of surgical and medical care, not elsewhere classified

138

0.79

0.35

1.1

—

Contact with and exposure to communicable diseases

318

1.16

0.35

1.0

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

285

0.88

0.34

1.0

—

Exclusions for E4_PCOS_BROAD

145

0.76

0.34

1.0

—

Hypothyroidism, strict autoimmune

0.75

0.34

1.3

1.1

—

Diabetes, insulin treatment (Kela reimbursement)

0.76

0.34

1.2

1.0

—

Exposure to unspecified factor

324

1.13

0.34

1.0

—

Low back pain

1.38

0.34

1.3

1.1

—

Any reimbursement code in KELA

252

0.87

0.34

1.0

—

Cerebral palsy and other paralytic syndromes

1.34

0.34

1.0

—

Pediculosis, acariasis and other infestations

1.34

0.34

1.1

1.0

—

Infections of the skin and subcutaneous tissue

308

1.16

0.34

1.0

—

Dental caries, including avohilmo

273

0.88

0.33

1.0

—

Congenital malformations of pulmonary and tricuspid valves

0.68

0.33

1.0

—

Nonorganic sleeping disorders, excluding more controls

100

1.30

0.33

1.1

1.0

—

Liquid cancers, helper endpoint

0.69

0.33

1.0

—

Postpartum haemorrhage due to anatomy

1.30

0.33

1.3

1.1

—

Examination and observation for other reasons

141

0.82

0.33

1.1

1.0

—

Other and unspecified tonsillitis

145

1.22

0.33

1.0

—

Vasomotor and allergic rhinitis

280

0.84

0.32

1.1

1.0

—

Chronic rhinitis, nasopharyngitis and pharyngitis

0.67

0.32

1.0

—

Dentofacial anomalies [including malocclusion]

288

1.14

0.32

1.0

—

Complications of medical and surgical care

132

0.77

0.32

1.2

1.0

—

Disorders of eyelid, lacrimal system and orbit

126

0.78

0.32

1.1

1.0

—

Other antidepressants

0.69

0.32

1.0

1.2

—

Adverse effects, not elsewhere classified

187

0.80

0.32

1.0

—

Anomalies of dental arch relationship, including avohilmo

240

1.16

0.31

1.0

—

Hypothyroidism (congenital or acquired)

100

0.79

0.31

1.2

1.0

—

Hypothyroidism and >3 levothyroxin purchases

100

0.79

0.31

1.2

1.0

—

Hypothyroidism, levothyroxine purchases

100

0.79

0.31

1.2

1.0

—

Cerebrovascular diseases

0.69

0.31

1.0

—

1.29

0.31

1.0

—

Congenital malformations of the nervous system

0.70

0.31

1.0

—

Cutaneous abscess, furuncle and carbuncle

0.71

0.30

1.1

1.0

—

Other fall from one level to another

193

1.19

0.30

1.0

—

Congenital malformations and deformations of the musculoskeletal system

257

1.16

0.30

1.0

—

Congenital malformations of the respiratory system

129

1.24

0.30

1.0

—

Atrial septal defect

227

0.83

0.30

1.0

—

Other and unspecified effects of external causes

207

0.82

0.30

1.0

—

Other dorsopathies, not elsewhere classified

1.27

0.30

1.3

1.1

—

Emotional disorders starting during childhood or adolescence

1.26

0.29

1.1

—

Bacterial pneumoniae

1.27

0.29

1.0

—

Congenital malformations of trachea and bronchus

1.23

0.29

1.0

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

110

0.73

0.28

1.0

—

Interstitial emphysema and related conditions originating in the perinatal period

0.69

0.28

1.0

—

Headache

185

1.17

0.28

1.1

1.0

—

Neurological diseases

343

0.91

0.28

1.0

—

Epilepsy

269

1.15

0.28

1.0

—

Fall involving playground equipment

1.26

0.27

1.0

—

Dermatitis

161

0.80

0.27

1.1

1.0

—

Chronic respiratory disease originating in the perinatal period

0.67

0.27

1.0

—

Patent foramen ovale

120

0.75

0.27

1.0

—

Diseases of external ear

117

0.77

0.27

1.0

—

Congenital malformation of biliary tract

0.67

0.27

1.0

—

Burns and corrosions of external body surface, specified by site

1.23

0.27

1.0

—

Superficial injury of wrist and hand

1.23

0.27

1.0

1.1

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

0.79

0.27

1.2

1.0

—

Other diseases of intestines

351

0.91

0.27

1.0

—

Superficial injury of ankle and foot

1.21

0.26

1.0

1.1

—

Diseases of the ear and mastoid process

235

1.11

0.26

1.0

—

Mood disorders, excluding more controls

1.28

0.26

1.0

1.1

—

Congenital malformations of gallbladder, bile ducts and liver

0.67

0.26

1.0

—

Bacterial infection, other or unspecified

154

0.82

0.26

1.0

—

Molar incisor enamel hypoplasia, with caries

1.27

0.26

1.0

—

Congenital malformations and deformations of the musculoskeletal system

261

1.14

0.26

1.0

—

Open wound of head

262

1.14

0.26

1.0

—

Other septicaemia

133

0.80

0.26

1.0

—

Weight loss

0.67

0.25

1.0

—

Gingivitis and periodontal diseases

111

0.84

0.25

1.1

1.0

—

Pain, not elsewhere classified

1.22

0.25

1.0

—

Fracture of forearm

1.18

0.24

1.0

1.1

—

Congenital malformations of genital organs

169

1.18

0.24

1.0

—

Type 1 diabetes, strict definition

1.17

0.24

1.0

—

Pollen allergy

241

0.86

0.24

1.1

1.0

—

Kidney transplant status

0.74

0.24

1.0

—

Purpura and other haemorrhagic conditions

0.74

0.24

1.0

—

Bacterial infection, other or unspecified

128

0.81

0.23

1.0

—

Other disorders originating in the perinatal period

190

1.17

0.23

1.0

—

Need for immunization against single bacterial diseases

1.30

0.23

1.0

—

Impacted teeth

1.23

0.23

1.1

—

Rash and other nonspecific skin eruption

1.32

0.23

1.2

1.0

—

Other skin changes

1.28

0.23

1.0

—

Allergic urticaria

1.24

0.23

1.1

1.0

—

Cholelithiasis

1.23

0.22

1.4

1.1

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

pH of Arterial cord blood

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS